ID CORE XT
Report
- Report Number
- 3006413195-2023-00020
- Event Type
- Malfunction
- Date Received
- October 9, 2023
- Date of Event
- July 18, 2023
- Report Date
- October 9, 2023
- Manufacturer
- PROGENIKA BIOPHARMA, S.A
- Product Code
- PEP
- UDI-DI
- 08437013457064
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SP
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE GENOMIC DNA SAMPLE WAS SENT TO GRIFOLS LABORATORY SOLUTION FOR DNA SEQUENCING. DNA SEQUENCING INTERROGATED SPECIFIC SEQUENCES: KEL GENE EXONS 1-9. THE KEL GENOTYPE DETECTED TWO KEL*K ALLELES IN AGREEMENT WITH ID CORE XT BUT ALSO A HOMOZYGOUS MUTATION C.1546C>T REPORTED AS KO ALLELE KEL*02N.17. THIS MUTATION IS ASSOCIATED WITH A NULL KO PHENOTYPE WHICH EXPLAINS THE SEROLOGY DISCREPANCY. ID CORE XT REPORTED A PREDICTED K+ PHENOTYPE, BUT KEL*02N.17 ALLELE IS ASSOCIATED WITH A PREDICTED K- PHENOTYPE. THIS FALSE POSITIVE RESULT OBTAINED BY ID CORE XT IS CONSIDERED A DISCREPANT RESULT AND THEN A MALFUNCTION. THIS CASE REPORT IS ASSOCIATED WITH LIMITATIONS OF ID CORE XT ASSAY, AS DESCRIBED IN THE ID CORE XT PACKAGE INSERT (SEC 1 AND 10 ASSAY LIMITATIONS).
IT WAS REPORTED THAT THE SAMPLE 8074933, FROM MADRID BLOOD TRANSFUSION CENTER, WAS TESTED WITH SEROLOGY. THE TEST RESULT WAS NEGATIVE (K-), WHICH CONTRASTED WITH THE MOLECULAR TYPING PERFORMED ON (B)(6) 2023, USING THE ID CORE XT ASSAY WHICH PROVIDED POSITIVE RESULTS (K+) WITH ID CORE XT ANALYSIS SOFTWARE V3.0.2.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1121226 | ID CORE XT | ANTIGEN GENOTYPING TEST | PEP | PROGENIKA BIOPHARMA, S.A | 0203000029 | 08437013457064 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |